Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-016287
Filing Date
2025-06-09
Accepted
2025-06-09 16:45:11
Documents
1
Period of Report
2025-06-05

Document Format Files

Seq Description Document Type Size
1 form4-06092025_040601.html 4  
1 form4-06092025_040601.xml 4 4147
  Complete submission text file 0001415889-25-016287.txt   5631
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Issuer) CIK: 0001660334 (see all company filings)

EIN.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O FORTE BIOSCIENCES, INC. 1124 W. CARSON ST., MRL BLDG 3-320 TORRANCE CA 90502
Business Address
Eichenfield Lawrence (Reporting) CIK: 0001814892 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38529 | Film No.: 251034730